B2B unit - delivering intelligent solutions

To meet the business needs of our company, Polpharma has created a new Business to Business (B2B) cooperation venture with our strategic partner Farmaprojects. The new venture is responsible for selling Polpharma Group and Farmaprojects to business clients.

  • products and services—licenses,
  • finished dosage forms and active pharmaceutical ingredients
  • contract manufacturing services

By concentrating these efforts in a single area, we are able to coordinate relationships with business clients and utilize the potential of our companies more effectively. Polpharma Group and Farmaprojects are thus joining the leading players on the global B2B market, with sales of over PLN 400 million.

For more information log on to